NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering the NCI Small Grants Program for Cancer Research through the R03 Clinical Trial Optional mechanism for the years 2023 to 2025. This program aims to support small-scale research projects focused on cancer, which can be executed quickly with limited resources, including pilot studies, secondary data analyses, and the development of research methodologies. Funding is available for direct costs up to $50,000 per year, with a maximum project duration of two years, and applications are currently open with multiple cycles throughout the funding period. Interested applicants can find more information and guidelines at the provided link and should direct inquiries to grantsinfo@nih.gov.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.